Viyash Scientific Limited — Financials & Forensics
Sector: Healthcare · NSE: VIYASH · BSE: 512529 · ISIN: INE807F01027
08 Sep 2026
Add VIYASH to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹1,413 Cr | ₹1,421 Cr | ₹1,370 Cr | ₹1,551 Cr | ₹3,420 Cr |
| EBITDA | ₹109 Cr | ₹12 Cr | ₹61 Cr | ₹162 Cr | ₹653 Cr |
| EBITDA margin | 7.7% | 0.8% | 4.5% | 10.4% | 19.1% |
| Profit after tax | ₹45 Cr | ₹-122 Cr | ₹-30 Cr | ₹32 Cr | ₹225 Cr |
Deeper analysis
Recent filings by Viyash Scientific Limited
-
Allotment of ESOP
04 Sep 2026 · Insider Trading
-
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of
27 Aug 2026 · Insider Trading
-
Earning call Transcript Q1 FY 2026-27
16 Aug 2026 · Financial Results
Never miss a filing again
About Viyash Scientific Limited on Indian Stock Alerts
Indian Stock Alerts tracks Viyash Scientific Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.